Structure

Physi-Chem Properties

Molecular Weight:  354.22
Volume:  385.327
LogP:  4.721
LogD:  4.223
LogS:  -4.324
# Rotatable Bonds:  2
TPSA:  49.69
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.707
Synthetic Accessibility Score:  4.635
Fsp3:  0.565
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.775
MDCK Permeability:  3.209647547919303e-05
Pgp-inhibitor:  0.144
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.056
Plasma Protein Binding (PPB):  99.4566421508789%
Volume Distribution (VD):  3.871
Pgp-substrate:  1.3469586372375488%

ADMET: Metabolism

CYP1A2-inhibitor:  0.255
CYP1A2-substrate:  0.848
CYP2C19-inhibitor:  0.664
CYP2C19-substrate:  0.826
CYP2C9-inhibitor:  0.857
CYP2C9-substrate:  0.864
CYP2D6-inhibitor:  0.789
CYP2D6-substrate:  0.542
CYP3A4-inhibitor:  0.744
CYP3A4-substrate:  0.83

ADMET: Excretion

Clearance (CL):  9.781
Half-life (T1/2):  0.136

ADMET: Toxicity

hERG Blockers:  0.058
Human Hepatotoxicity (H-HT):  0.076
Drug-inuced Liver Injury (DILI):  0.079
AMES Toxicity:  0.046
Rat Oral Acute Toxicity:  0.642
Maximum Recommended Daily Dose:  0.919
Skin Sensitization:  0.939
Carcinogencity:  0.657
Eye Corrosion:  0.003
Eye Irritation:  0.118
Respiratory Toxicity:  0.942

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC133652

Natural Product ID:  NPC133652
Common Name*:   Dysideanone B
IUPAC Name:   (3aS,6S,6aR,11bS,11cS)-9-ethoxy-3a,6,6a-trimethyl-3-methylidene-1,2,4,5,6,7,11b,11c-octahydrobenzo[a]phenalene-8,11-dione
Synonyms:  
Standard InCHIKey:  ORESXGBZWCQKQL-XJMVPUPPSA-N
Standard InCHI:  InChI=1S/C23H30O3/c1-6-26-18-11-17(24)19-15-8-7-13(2)22(4)10-9-14(3)23(5,21(15)22)12-16(19)20(18)25/h11,14-15,21H,2,6-10,12H2,1,3-5H3/t14-,15+,21+,22+,23+/m0/s1
SMILES:  CCOC1=CC(=O)C2=C(C[C@]3(C)[C@@H](C)CC[C@]4(C)C(=C)CC[C@H]2[C@@H]34)C1=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3109478
PubChem CID:   76321231
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5563 Dysidea avara Species Dysideidae Eukaryota n.a. n.a. n.a. DOI[10.1021/jo00050a043]
NPO5563 Dysidea avara Species Dysideidae Eukaryota n.a. South China Sea n.a. PMID[24547794]
NPO5563 Dysidea avara Species Dysideidae Eukaryota n.a. n.a. n.a. PMID[2778453]
NPO5563 Dysidea avara Species Dysideidae Eukaryota n.a. Bay of Naples, Italy n.a. PMID[7714539]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 = 9400.0 nM PMID[490280]
NPT165 Cell Line HeLa Homo sapiens IC50 = 7100.0 nM PMID[490280]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC133652 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9494 High Similarity NPC474085
0.9036 High Similarity NPC241512
0.9036 High Similarity NPC263997
0.9036 High Similarity NPC8518
0.9036 High Similarity NPC6185
0.9036 High Similarity NPC132228
0.8953 High Similarity NPC223093
0.8659 High Similarity NPC108955
0.8554 High Similarity NPC55869
0.8537 High Similarity NPC476177
0.8523 High Similarity NPC475823
0.8523 High Similarity NPC474209
0.8452 Intermediate Similarity NPC103486
0.8372 Intermediate Similarity NPC474680
0.8353 Intermediate Similarity NPC53733
0.8333 Intermediate Similarity NPC475833
0.8333 Intermediate Similarity NPC99308
0.8293 Intermediate Similarity NPC472300
0.8242 Intermediate Similarity NPC23170
0.8214 Intermediate Similarity NPC2482
0.8193 Intermediate Similarity NPC23778
0.8171 Intermediate Similarity NPC92080
0.8161 Intermediate Similarity NPC2709
0.814 Intermediate Similarity NPC105803
0.8132 Intermediate Similarity NPC263780
0.8125 Intermediate Similarity NPC179208
0.8118 Intermediate Similarity NPC149237
0.8118 Intermediate Similarity NPC225515
0.8118 Intermediate Similarity NPC121984
0.8095 Intermediate Similarity NPC27817
0.809 Intermediate Similarity NPC478259
0.809 Intermediate Similarity NPC478261
0.809 Intermediate Similarity NPC478260
0.8072 Intermediate Similarity NPC283087
0.8068 Intermediate Similarity NPC94666
0.8046 Intermediate Similarity NPC237712
0.8046 Intermediate Similarity NPC312660
0.8022 Intermediate Similarity NPC470036
0.8022 Intermediate Similarity NPC174167
0.8022 Intermediate Similarity NPC26865
0.8 Intermediate Similarity NPC280833
0.8 Intermediate Similarity NPC104861
0.7976 Intermediate Similarity NPC469996
0.7976 Intermediate Similarity NPC189485
0.7976 Intermediate Similarity NPC30321
0.7976 Intermediate Similarity NPC478247
0.7976 Intermediate Similarity NPC478246
0.7955 Intermediate Similarity NPC469993
0.7955 Intermediate Similarity NPC323765
0.7952 Intermediate Similarity NPC470525
0.7952 Intermediate Similarity NPC26504
0.7952 Intermediate Similarity NPC1254
0.7935 Intermediate Similarity NPC211230
0.7931 Intermediate Similarity NPC8091
0.7912 Intermediate Similarity NPC38952
0.7907 Intermediate Similarity NPC116797
0.7901 Intermediate Similarity NPC474539
0.7889 Intermediate Similarity NPC53454
0.7882 Intermediate Similarity NPC475681
0.7865 Intermediate Similarity NPC327115
0.7865 Intermediate Similarity NPC195640
0.7849 Intermediate Similarity NPC474882
0.7849 Intermediate Similarity NPC474328
0.7841 Intermediate Similarity NPC53385
0.7841 Intermediate Similarity NPC469569
0.7826 Intermediate Similarity NPC218301
0.7816 Intermediate Similarity NPC310989
0.7816 Intermediate Similarity NPC163236
0.7802 Intermediate Similarity NPC477973
0.7802 Intermediate Similarity NPC65615
0.7802 Intermediate Similarity NPC469546
0.7802 Intermediate Similarity NPC68148
0.7802 Intermediate Similarity NPC112454
0.7802 Intermediate Similarity NPC305039
0.7791 Intermediate Similarity NPC476809
0.7791 Intermediate Similarity NPC474956
0.7791 Intermediate Similarity NPC267517
0.7791 Intermediate Similarity NPC18955
0.7791 Intermediate Similarity NPC472478
0.7778 Intermediate Similarity NPC230016
0.7778 Intermediate Similarity NPC470523
0.7778 Intermediate Similarity NPC38885
0.7778 Intermediate Similarity NPC93778
0.7778 Intermediate Similarity NPC30421
0.7766 Intermediate Similarity NPC777
0.7766 Intermediate Similarity NPC147232
0.7765 Intermediate Similarity NPC4827
0.7765 Intermediate Similarity NPC476808
0.7753 Intermediate Similarity NPC469948
0.7753 Intermediate Similarity NPC474537
0.7753 Intermediate Similarity NPC90287
0.7753 Intermediate Similarity NPC33663
0.7753 Intermediate Similarity NPC33881
0.7753 Intermediate Similarity NPC189311
0.7753 Intermediate Similarity NPC32037
0.775 Intermediate Similarity NPC188292
0.775 Intermediate Similarity NPC260474
0.7738 Intermediate Similarity NPC110725
0.7727 Intermediate Similarity NPC291999
0.7727 Intermediate Similarity NPC307258
0.7727 Intermediate Similarity NPC309309
0.7717 Intermediate Similarity NPC113393
0.7717 Intermediate Similarity NPC328141
0.7711 Intermediate Similarity NPC147438
0.7711 Intermediate Similarity NPC128346
0.7711 Intermediate Similarity NPC219232
0.7708 Intermediate Similarity NPC478056
0.7701 Intermediate Similarity NPC278459
0.7701 Intermediate Similarity NPC474955
0.7701 Intermediate Similarity NPC471898
0.7701 Intermediate Similarity NPC3915
0.7692 Intermediate Similarity NPC470524
0.7692 Intermediate Similarity NPC472302
0.7692 Intermediate Similarity NPC206060
0.7692 Intermediate Similarity NPC307298
0.7677 Intermediate Similarity NPC40170
0.7674 Intermediate Similarity NPC192329
0.7674 Intermediate Similarity NPC472490
0.7667 Intermediate Similarity NPC472974
0.7667 Intermediate Similarity NPC474732
0.7667 Intermediate Similarity NPC474733
0.7667 Intermediate Similarity NPC31564
0.7667 Intermediate Similarity NPC474778
0.7667 Intermediate Similarity NPC145879
0.7667 Intermediate Similarity NPC20688
0.7667 Intermediate Similarity NPC51014
0.7653 Intermediate Similarity NPC308351
0.7653 Intermediate Similarity NPC271266
0.7647 Intermediate Similarity NPC476811
0.7647 Intermediate Similarity NPC165711
0.764 Intermediate Similarity NPC476412
0.764 Intermediate Similarity NPC58841
0.764 Intermediate Similarity NPC329043
0.764 Intermediate Similarity NPC161423
0.764 Intermediate Similarity NPC144258
0.764 Intermediate Similarity NPC321187
0.764 Intermediate Similarity NPC180834
0.764 Intermediate Similarity NPC85774
0.764 Intermediate Similarity NPC473246
0.764 Intermediate Similarity NPC227064
0.764 Intermediate Similarity NPC214043
0.7634 Intermediate Similarity NPC99380
0.7634 Intermediate Similarity NPC248913
0.7614 Intermediate Similarity NPC48362
0.7614 Intermediate Similarity NPC151519
0.7614 Intermediate Similarity NPC470813
0.7614 Intermediate Similarity NPC142683
0.7614 Intermediate Similarity NPC100297
0.7614 Intermediate Similarity NPC328351
0.7614 Intermediate Similarity NPC327969
0.7614 Intermediate Similarity NPC321289
0.7609 Intermediate Similarity NPC119416
0.7609 Intermediate Similarity NPC50070
0.7609 Intermediate Similarity NPC184663
0.7609 Intermediate Similarity NPC310010
0.7609 Intermediate Similarity NPC326627
0.7609 Intermediate Similarity NPC474700
0.7604 Intermediate Similarity NPC170131
0.7586 Intermediate Similarity NPC304795
0.7586 Intermediate Similarity NPC287063
0.7582 Intermediate Similarity NPC471728
0.7582 Intermediate Similarity NPC58063
0.7582 Intermediate Similarity NPC477228
0.7582 Intermediate Similarity NPC272039
0.7582 Intermediate Similarity NPC220930
0.7582 Intermediate Similarity NPC475740
0.7579 Intermediate Similarity NPC295347
0.7579 Intermediate Similarity NPC274417
0.7576 Intermediate Similarity NPC131366
0.7561 Intermediate Similarity NPC251929
0.7561 Intermediate Similarity NPC265782
0.7561 Intermediate Similarity NPC2634
0.7558 Intermediate Similarity NPC74410
0.7558 Intermediate Similarity NPC62336
0.7558 Intermediate Similarity NPC115515
0.7556 Intermediate Similarity NPC478245
0.7556 Intermediate Similarity NPC255174
0.7556 Intermediate Similarity NPC476426
0.7556 Intermediate Similarity NPC470223
0.7553 Intermediate Similarity NPC229976
0.7553 Intermediate Similarity NPC271652
0.7553 Intermediate Similarity NPC79117
0.7531 Intermediate Similarity NPC310992
0.7531 Intermediate Similarity NPC155198
0.7531 Intermediate Similarity NPC87141
0.7529 Intermediate Similarity NPC263582
0.7529 Intermediate Similarity NPC899
0.7528 Intermediate Similarity NPC288281
0.7528 Intermediate Similarity NPC470047
0.7528 Intermediate Similarity NPC22611
0.7528 Intermediate Similarity NPC193198
0.7528 Intermediate Similarity NPC470046
0.7527 Intermediate Similarity NPC159748
0.7527 Intermediate Similarity NPC129913
0.7527 Intermediate Similarity NPC101651
0.7527 Intermediate Similarity NPC212369
0.7527 Intermediate Similarity NPC85173
0.75 Intermediate Similarity NPC14151
0.75 Intermediate Similarity NPC474845
0.75 Intermediate Similarity NPC58052

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC133652 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8434 Intermediate Similarity NPD4695 Discontinued
0.8295 Intermediate Similarity NPD6672 Approved
0.8295 Intermediate Similarity NPD5737 Approved
0.7889 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7865 Intermediate Similarity NPD6409 Approved
0.7865 Intermediate Similarity NPD6684 Approved
0.7865 Intermediate Similarity NPD5330 Approved
0.7865 Intermediate Similarity NPD7521 Approved
0.7865 Intermediate Similarity NPD7334 Approved
0.7865 Intermediate Similarity NPD7146 Approved
0.7802 Intermediate Similarity NPD6904 Approved
0.7802 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD6080 Approved
0.7802 Intermediate Similarity NPD6673 Approved
0.7778 Intermediate Similarity NPD3573 Approved
0.7766 Intermediate Similarity NPD5695 Phase 3
0.7765 Intermediate Similarity NPD3617 Approved
0.7717 Intermediate Similarity NPD5692 Phase 3
0.7692 Intermediate Similarity NPD6903 Approved
0.7667 Intermediate Similarity NPD5690 Phase 2
0.7667 Intermediate Similarity NPD5279 Phase 3
0.7667 Intermediate Similarity NPD6098 Approved
0.764 Intermediate Similarity NPD3133 Approved
0.764 Intermediate Similarity NPD4197 Approved
0.764 Intermediate Similarity NPD3665 Phase 1
0.764 Intermediate Similarity NPD3666 Approved
0.7634 Intermediate Similarity NPD6050 Approved
0.7634 Intermediate Similarity NPD5693 Phase 1
0.7634 Intermediate Similarity NPD5694 Approved
0.7614 Intermediate Similarity NPD3667 Approved
0.7609 Intermediate Similarity NPD4753 Phase 2
0.7604 Intermediate Similarity NPD6084 Phase 2
0.7604 Intermediate Similarity NPD6083 Phase 2
0.7561 Intermediate Similarity NPD4691 Approved
0.7556 Intermediate Similarity NPD5329 Approved
0.7526 Intermediate Similarity NPD5696 Approved
0.7474 Intermediate Similarity NPD7748 Approved
0.7474 Intermediate Similarity NPD7900 Approved
0.7474 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD5280 Approved
0.7473 Intermediate Similarity NPD3618 Phase 1
0.7473 Intermediate Similarity NPD4694 Approved
0.7444 Intermediate Similarity NPD4786 Approved
0.7444 Intermediate Similarity NPD3668 Phase 3
0.7439 Intermediate Similarity NPD4137 Phase 3
0.7416 Intermediate Similarity NPD4223 Phase 3
0.7416 Intermediate Similarity NPD4221 Approved
0.7416 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD5210 Approved
0.7396 Intermediate Similarity NPD4629 Approved
0.7349 Intermediate Similarity NPD4747 Approved
0.732 Intermediate Similarity NPD5222 Approved
0.732 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD5221 Approved
0.7312 Intermediate Similarity NPD5208 Approved
0.7294 Intermediate Similarity NPD4058 Approved
0.7284 Intermediate Similarity NPD6108 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7515 Phase 2
0.7263 Intermediate Similarity NPD6079 Approved
0.7245 Intermediate Similarity NPD5173 Approved
0.7245 Intermediate Similarity NPD7902 Approved
0.7234 Intermediate Similarity NPD5328 Approved
0.7216 Intermediate Similarity NPD5654 Approved
0.7188 Intermediate Similarity NPD6399 Phase 3
0.7184 Intermediate Similarity NPD5697 Approved
0.7158 Intermediate Similarity NPD5207 Approved
0.7143 Intermediate Similarity NPD7732 Phase 3
0.7143 Intermediate Similarity NPD4697 Phase 3
0.7115 Intermediate Similarity NPD6899 Approved
0.7115 Intermediate Similarity NPD6011 Approved
0.7115 Intermediate Similarity NPD6881 Approved
0.71 Intermediate Similarity NPD5286 Approved
0.71 Intermediate Similarity NPD5285 Approved
0.71 Intermediate Similarity NPD4696 Approved
0.7097 Intermediate Similarity NPD4519 Discontinued
0.7097 Intermediate Similarity NPD5205 Approved
0.7097 Intermediate Similarity NPD4693 Phase 3
0.7097 Intermediate Similarity NPD4689 Approved
0.7097 Intermediate Similarity NPD4138 Approved
0.7097 Intermediate Similarity NPD4690 Approved
0.7097 Intermediate Similarity NPD4688 Approved
0.7097 Intermediate Similarity NPD4623 Approved
0.7097 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5733 Approved
0.7093 Intermediate Similarity NPD4687 Approved
0.7087 Intermediate Similarity NPD6402 Approved
0.7087 Intermediate Similarity NPD5739 Approved
0.7087 Intermediate Similarity NPD6675 Approved
0.7087 Intermediate Similarity NPD7128 Approved
0.7071 Intermediate Similarity NPD4755 Approved
0.7071 Intermediate Similarity NPD5959 Approved
0.7059 Intermediate Similarity NPD5276 Approved
0.7048 Intermediate Similarity NPD6013 Approved
0.7048 Intermediate Similarity NPD6014 Approved
0.7048 Intermediate Similarity NPD6012 Approved
0.7041 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD5223 Approved
0.7019 Intermediate Similarity NPD5701 Approved
0.701 Intermediate Similarity NPD4202 Approved
0.6989 Remote Similarity NPD1694 Approved
0.6981 Remote Similarity NPD7290 Approved
0.6981 Remote Similarity NPD6883 Approved
0.6981 Remote Similarity NPD7102 Approved
0.6961 Remote Similarity NPD4633 Approved
0.6961 Remote Similarity NPD5226 Approved
0.6961 Remote Similarity NPD5211 Phase 2
0.6961 Remote Similarity NPD5225 Approved
0.6961 Remote Similarity NPD5224 Approved
0.6957 Remote Similarity NPD4788 Approved
0.6952 Remote Similarity NPD7320 Approved
0.6939 Remote Similarity NPD6001 Approved
0.6931 Remote Similarity NPD4700 Approved
0.6923 Remote Similarity NPD8028 Phase 2
0.6916 Remote Similarity NPD6649 Approved
0.6916 Remote Similarity NPD6650 Approved
0.6916 Remote Similarity NPD6847 Approved
0.6916 Remote Similarity NPD6617 Approved
0.6916 Remote Similarity NPD6869 Approved
0.6916 Remote Similarity NPD8130 Phase 1
0.6905 Remote Similarity NPD3621 Clinical (unspecified phase)
0.6893 Remote Similarity NPD5174 Approved
0.6893 Remote Similarity NPD5175 Approved
0.6889 Remote Similarity NPD4195 Approved
0.6887 Remote Similarity NPD6373 Approved
0.6887 Remote Similarity NPD6372 Approved
0.6857 Remote Similarity NPD6614 Approved
0.6852 Remote Similarity NPD6882 Approved
0.6852 Remote Similarity NPD8297 Approved
0.6837 Remote Similarity NPD5133 Approved
0.6827 Remote Similarity NPD5141 Approved
0.68 Remote Similarity NPD7614 Phase 1
0.6768 Remote Similarity NPD5282 Discontinued
0.6762 Remote Similarity NPD6008 Approved
0.6759 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6735 Remote Similarity NPD5281 Approved
0.6735 Remote Similarity NPD5284 Approved
0.6731 Remote Similarity NPD4754 Approved
0.6698 Remote Similarity NPD6412 Phase 2
0.6667 Remote Similarity NPD3704 Approved
0.6667 Remote Similarity NPD6274 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6636 Remote Similarity NPD4730 Approved
0.6636 Remote Similarity NPD5128 Approved
0.6636 Remote Similarity NPD4729 Approved
0.6636 Remote Similarity NPD5168 Approved
0.6635 Remote Similarity NPD5091 Approved
0.6633 Remote Similarity NPD4096 Approved
0.663 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6607 Remote Similarity NPD6317 Approved
0.6604 Remote Similarity NPD4768 Approved
0.6604 Remote Similarity NPD4767 Approved
0.6598 Remote Similarity NPD4518 Approved
0.6596 Remote Similarity NPD3527 Clinical (unspecified phase)
0.6566 Remote Similarity NPD6411 Approved
0.6559 Remote Similarity NPD4692 Approved
0.6559 Remote Similarity NPD4139 Approved
0.6556 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6549 Remote Similarity NPD6314 Approved
0.6549 Remote Similarity NPD6335 Approved
0.6549 Remote Similarity NPD6313 Approved
0.6522 Remote Similarity NPD7645 Phase 2
0.6514 Remote Similarity NPD5135 Approved
0.6514 Remote Similarity NPD5249 Phase 3
0.6514 Remote Similarity NPD5247 Approved
0.6514 Remote Similarity NPD5250 Approved
0.6514 Remote Similarity NPD5248 Approved
0.6514 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6514 Remote Similarity NPD4634 Approved
0.6514 Remote Similarity NPD5251 Approved
0.6514 Remote Similarity NPD5169 Approved
0.6506 Remote Similarity NPD2664 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7101 Approved
0.6491 Remote Similarity NPD7100 Approved
0.6486 Remote Similarity NPD4632 Approved
0.6484 Remote Similarity NPD4756 Discovery
0.646 Remote Similarity NPD7115 Discovery
0.646 Remote Similarity NPD6009 Approved
0.6458 Remote Similarity NPD1696 Phase 3
0.6455 Remote Similarity NPD5217 Approved
0.6455 Remote Similarity NPD5127 Approved
0.6455 Remote Similarity NPD5216 Approved
0.6455 Remote Similarity NPD5215 Approved
0.6444 Remote Similarity NPD6942 Approved
0.6444 Remote Similarity NPD7339 Approved
0.6435 Remote Similarity NPD6054 Approved
0.6435 Remote Similarity NPD6319 Approved
0.642 Remote Similarity NPD287 Approved
0.6415 Remote Similarity NPD6052 Approved
0.6379 Remote Similarity NPD6016 Approved
0.6379 Remote Similarity NPD5983 Phase 2
0.6379 Remote Similarity NPD6015 Approved
0.6364 Remote Similarity NPD6101 Approved
0.6364 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6346 Remote Similarity NPD7638 Approved
0.6339 Remote Similarity NPD7094 Approved
0.6339 Remote Similarity NPD6858 Approved
0.6325 Remote Similarity NPD5988 Approved
0.6325 Remote Similarity NPD6370 Approved
0.6293 Remote Similarity NPD6059 Approved
0.6289 Remote Similarity NPD7520 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data